Rémuzat, C., Toumi, M., & Falissard, B. (2013). New drug regulations in France: What are the impacts on market access? Part 2 – impacts on market access and impacts for the pharmaceutical industry. J Mark Access Health Policy.
Citação norma ChicagoRémuzat, Cécile, Mondher Toumi, and Bruno Falissard. "New Drug Regulations in France: What Are the Impacts On Market Access? Part 2 – Impacts On Market Access and Impacts for the Pharmaceutical Industry." J Mark Access Health Policy 2013.
Citação norma MLARémuzat, Cécile, Mondher Toumi, and Bruno Falissard. "New Drug Regulations in France: What Are the Impacts On Market Access? Part 2 – Impacts On Market Access and Impacts for the Pharmaceutical Industry." J Mark Access Health Policy 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.